The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Contrast Agent Market Research Report 2024
Synopsis
Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.
The global Contrast Agent market was valued at US$ 5387 million in 2023 and is anticipated to reach US$ 6860.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Contrast Agents key players include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, etc. Global top four manufacturers hold a share over 75%.
Asia-Pacific is the largest market, with a share over 40%, followed by Europe, and North America, both have a share over 50 percent.
In terms of product, X-ray and CT is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospitals, followed by Clinics.
This report aims to provide a comprehensive presentation of the global market for Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contrast Agent.
Report Scope
The Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare Pharmaceuticals
Medrad
Lantheus Medical
ACIST Medical Systems
AMAG Pharmaceuticals
Pinyons Medical Technology
Targeson
Beekley Medical
Mallinckrodt Pharmaceuticals
Nova Biomedical
NycomedAmersham
Daiichi
Medtronic
GE Healthcare
Bracco Diagnostic
Guerbet
Segment by Type
Gadolinium-Based Contrast Media
Barium-Based Contrast Media
Iodinated Contrast Media
Segment by Application
Interventional Cardiology
Radiology
Interventional Radiology
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.
The global Contrast Agent market was valued at US$ 5387 million in 2023 and is anticipated to reach US$ 6860.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Contrast Agents key players include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, etc. Global top four manufacturers hold a share over 75%.
Asia-Pacific is the largest market, with a share over 40%, followed by Europe, and North America, both have a share over 50 percent.
In terms of product, X-ray and CT is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospitals, followed by Clinics.
This report aims to provide a comprehensive presentation of the global market for Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contrast Agent.
Report Scope
The Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare Pharmaceuticals
Medrad
Lantheus Medical
ACIST Medical Systems
AMAG Pharmaceuticals
Pinyons Medical Technology
Targeson
Beekley Medical
Mallinckrodt Pharmaceuticals
Nova Biomedical
NycomedAmersham
Daiichi
Medtronic
GE Healthcare
Bracco Diagnostic
Guerbet
Segment by Type
Gadolinium-Based Contrast Media
Barium-Based Contrast Media
Iodinated Contrast Media
Segment by Application
Interventional Cardiology
Radiology
Interventional Radiology
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Contrast Agent Market Overview
1.1 Product Overview and Scope of Contrast Agent
1.2 Contrast Agent Segment by Type
1.2.1 Global Contrast Agent Market Value Comparison by Type (2024-2030)
1.2.2 Gadolinium-Based Contrast Media
1.2.3 Barium-Based Contrast Media
1.2.4 Iodinated Contrast Media
1.3 Contrast Agent Segment by Application
1.3.1 Global Contrast Agent Market Value by Application: (2024-2030)
1.3.2 Interventional Cardiology
1.3.3 Radiology
1.3.4 Interventional Radiology
1.4 Global Contrast Agent Market Size Estimates and Forecasts
1.4.1 Global Contrast Agent Revenue 2019-2030
1.4.2 Global Contrast Agent Sales 2019-2030
1.4.3 Global Contrast Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Contrast Agent Market Competition by Manufacturers
2.1 Global Contrast Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Contrast Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Contrast Agent Average Price by Manufacturers (2019-2024)
2.4 Global Contrast Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contrast Agent, Product Type & Application
2.7 Contrast Agent Market Competitive Situation and Trends
2.7.1 Contrast Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Contrast Agent Players Market Share by Revenue
2.7.3 Global Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Contrast Agent Retrospective Market Scenario by Region
3.1 Global Contrast Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Contrast Agent Global Contrast Agent Sales by Region: 2019-2030
3.2.1 Global Contrast Agent Sales by Region: 2019-2024
3.2.2 Global Contrast Agent Sales by Region: 2025-2030
3.3 Global Contrast Agent Global Contrast Agent Revenue by Region: 2019-2030
3.3.1 Global Contrast Agent Revenue by Region: 2019-2024
3.3.2 Global Contrast Agent Revenue by Region: 2025-2030
3.4 North America Contrast Agent Market Facts & Figures by Country
3.4.1 North America Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Contrast Agent Sales by Country (2019-2030)
3.4.3 North America Contrast Agent Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Contrast Agent Market Facts & Figures by Country
3.5.1 Europe Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Contrast Agent Sales by Country (2019-2030)
3.5.3 Europe Contrast Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contrast Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Contrast Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Contrast Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Contrast Agent Market Facts & Figures by Country
3.7.1 Latin America Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Contrast Agent Sales by Country (2019-2030)
3.7.3 Latin America Contrast Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contrast Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Contrast Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Contrast Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Contrast Agent Sales by Type (2019-2030)
4.1.1 Global Contrast Agent Sales by Type (2019-2024)
4.1.2 Global Contrast Agent Sales by Type (2025-2030)
4.1.3 Global Contrast Agent Sales Market Share by Type (2019-2030)
4.2 Global Contrast Agent Revenue by Type (2019-2030)
4.2.1 Global Contrast Agent Revenue by Type (2019-2024)
4.2.2 Global Contrast Agent Revenue by Type (2025-2030)
4.2.3 Global Contrast Agent Revenue Market Share by Type (2019-2030)
4.3 Global Contrast Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Contrast Agent Sales by Application (2019-2030)
5.1.1 Global Contrast Agent Sales by Application (2019-2024)
5.1.2 Global Contrast Agent Sales by Application (2025-2030)
5.1.3 Global Contrast Agent Sales Market Share by Application (2019-2030)
5.2 Global Contrast Agent Revenue by Application (2019-2030)
5.2.1 Global Contrast Agent Revenue by Application (2019-2024)
5.2.2 Global Contrast Agent Revenue by Application (2025-2030)
5.2.3 Global Contrast Agent Revenue Market Share by Application (2019-2030)
5.3 Global Contrast Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare Pharmaceuticals
6.1.1 Bayer Healthcare Pharmaceuticals Corporation Information
6.1.2 Bayer Healthcare Pharmaceuticals Description and Business Overview
6.1.3 Bayer Healthcare Pharmaceuticals Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare Pharmaceuticals Contrast Agent Product Portfolio
6.1.5 Bayer Healthcare Pharmaceuticals Recent Developments/Updates
6.2 Medrad
6.2.1 Medrad Corporation Information
6.2.2 Medrad Description and Business Overview
6.2.3 Medrad Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medrad Contrast Agent Product Portfolio
6.2.5 Medrad Recent Developments/Updates
6.3 Lantheus Medical
6.3.1 Lantheus Medical Corporation Information
6.3.2 Lantheus Medical Description and Business Overview
6.3.3 Lantheus Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lantheus Medical Contrast Agent Product Portfolio
6.3.5 Lantheus Medical Recent Developments/Updates
6.4 ACIST Medical Systems
6.4.1 ACIST Medical Systems Corporation Information
6.4.2 ACIST Medical Systems Description and Business Overview
6.4.3 ACIST Medical Systems Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ACIST Medical Systems Contrast Agent Product Portfolio
6.4.5 ACIST Medical Systems Recent Developments/Updates
6.5 AMAG Pharmaceuticals
6.5.1 AMAG Pharmaceuticals Corporation Information
6.5.2 AMAG Pharmaceuticals Description and Business Overview
6.5.3 AMAG Pharmaceuticals Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AMAG Pharmaceuticals Contrast Agent Product Portfolio
6.5.5 AMAG Pharmaceuticals Recent Developments/Updates
6.6 Pinyons Medical Technology
6.6.1 Pinyons Medical Technology Corporation Information
6.6.2 Pinyons Medical Technology Description and Business Overview
6.6.3 Pinyons Medical Technology Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pinyons Medical Technology Contrast Agent Product Portfolio
6.6.5 Pinyons Medical Technology Recent Developments/Updates
6.7 Targeson
6.6.1 Targeson Corporation Information
6.6.2 Targeson Description and Business Overview
6.6.3 Targeson Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Targeson Contrast Agent Product Portfolio
6.7.5 Targeson Recent Developments/Updates
6.8 Beekley Medical
6.8.1 Beekley Medical Corporation Information
6.8.2 Beekley Medical Description and Business Overview
6.8.3 Beekley Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Beekley Medical Contrast Agent Product Portfolio
6.8.5 Beekley Medical Recent Developments/Updates
6.9 Mallinckrodt Pharmaceuticals
6.9.1 Mallinckrodt Pharmaceuticals Corporation Information
6.9.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.9.3 Mallinckrodt Pharmaceuticals Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mallinckrodt Pharmaceuticals Contrast Agent Product Portfolio
6.9.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.10 Nova Biomedical
6.10.1 Nova Biomedical Corporation Information
6.10.2 Nova Biomedical Description and Business Overview
6.10.3 Nova Biomedical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nova Biomedical Contrast Agent Product Portfolio
6.10.5 Nova Biomedical Recent Developments/Updates
6.11 NycomedAmersham
6.11.1 NycomedAmersham Corporation Information
6.11.2 NycomedAmersham Contrast Agent Description and Business Overview
6.11.3 NycomedAmersham Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 NycomedAmersham Contrast Agent Product Portfolio
6.11.5 NycomedAmersham Recent Developments/Updates
6.12 Daiichi
6.12.1 Daiichi Corporation Information
6.12.2 Daiichi Contrast Agent Description and Business Overview
6.12.3 Daiichi Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Daiichi Contrast Agent Product Portfolio
6.12.5 Daiichi Recent Developments/Updates
6.13 Medtronic
6.13.1 Medtronic Corporation Information
6.13.2 Medtronic Contrast Agent Description and Business Overview
6.13.3 Medtronic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Medtronic Contrast Agent Product Portfolio
6.13.5 Medtronic Recent Developments/Updates
6.14 GE Healthcare
6.14.1 GE Healthcare Corporation Information
6.14.2 GE Healthcare Contrast Agent Description and Business Overview
6.14.3 GE Healthcare Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.14.4 GE Healthcare Contrast Agent Product Portfolio
6.14.5 GE Healthcare Recent Developments/Updates
6.15 Bracco Diagnostic
6.15.1 Bracco Diagnostic Corporation Information
6.15.2 Bracco Diagnostic Contrast Agent Description and Business Overview
6.15.3 Bracco Diagnostic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bracco Diagnostic Contrast Agent Product Portfolio
6.15.5 Bracco Diagnostic Recent Developments/Updates
6.16 Guerbet
6.16.1 Guerbet Corporation Information
6.16.2 Guerbet Contrast Agent Description and Business Overview
6.16.3 Guerbet Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Guerbet Contrast Agent Product Portfolio
6.16.5 Guerbet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contrast Agent Industry Chain Analysis
7.2 Contrast Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contrast Agent Production Mode & Process
7.4 Contrast Agent Sales and Marketing
7.4.1 Contrast Agent Sales Channels
7.4.2 Contrast Agent Distributors
7.5 Contrast Agent Customers
8 Contrast Agent Market Dynamics
8.1 Contrast Agent Industry Trends
8.2 Contrast Agent Market Drivers
8.3 Contrast Agent Market Challenges
8.4 Contrast Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
